{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:16:02Z","timestamp":1774952162464,"version":"3.50.1"},"reference-count":32,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Innovation Fund of The First Affiliated Hospital of Harbin Medical University","award":["2024M35"],"award-info":[{"award-number":["2024M35"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Gastric cancer (GC) is among the most frequently diagnosed malignancies worldwide. Identifying novel therapeutic targets is of great significance. Methods: GC-related RNA-seq data and matched clinical information were retrieved from the publicly available The Cancer Genome Atlas (TCGA) database. The epithelial-mesenchymal transition (EMT) scores of GC and normal tissues were calculated using the gene set variation analysis (GSVA) package. Weighted gene coexpression network analysis (WGCNA) was applied to identify modules associated with EMT. The survival and clinical relevance of EMT-related core genes were analyzed, and carbohydrate sulfotransferase 1 (CHST1) was selected for further investigation. CHST1 expression was validated in patient-derived GC tissues and GC cell lines. Subsequently, CHST1 expression and mitogen-activated protein kinase (MAPK)\/extracellular signal-regulated kinase (ERK) signaling pathway activity were modulated in AGS cells to evaluate their effects on cell proliferation, apoptosis, migration, and EMT. In vivo experiments were conducted to elucidate the involvement of CHST1 expression in GC growth. Results: The EMT score was markedly higher in GC tissues than in normal tissues. Within the EMT-related module, 7 hub genes (CHST1, GPR176, OLFML2B, P4HA3, PDGFRB, SPARC, and VCAN) were closely associated with GC prognosis. CHST1 expression was strongly correlated with both the EMT score and T stage. As revealed by survival analysis, patients with high CHST1 expression had shorter overall survival than those with low expression. A marked up-regulation of CHST1 protein expression was observed in clinical GC tissues compared with normal tissues. In vitro, CHST1 expression was significantly elevated in GC cell lines. Inhibiting CHST1 expression in AGS and HGC27 cells suppressed cell proliferation, migration, as well as EMT, while simultaneously promoting apoptosis. In AGS cells, CHST1 regulated cell proliferation, apoptosis, migration, and EMT through the MAPK\/ERK signaling pathway. In vivo, CHST1 significantly promoted GC growth and increased the activity of the MAPK\/ERK signaling pathway. Conclusion: CHST1 is highly expressed in GC and may influence GC progression by regulating the MAPK\/ERK signaling pathway.<\/jats:p>","DOI":"10.31083\/fbl47627","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:36:33Z","timestamp":1774949793000},"source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics-Based Identification and Clinical Validation of CHST1 as a Potential Prognostic Gene Associated With EMT in Gastric Cancer"],"prefix":"10.31083","volume":"31","author":[{"given":"Xufu","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"},{"name":"Department of Gastroenterology, Heilongjiang Provincial Hospital, 150036 Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zetao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"},{"name":"Fifth Department of Medicine (Nephrology\/Endocrinology\/Rheumatology, Pneumonology), University Medical Center Mannheim, University of Heidelberg, 68167 Mannheim, Baden-Wurttemberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2550-6505","authenticated-orcid":true,"given":"Lijun","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a Cancer Journal for Clinicians. 2021; 71: 209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"L\u00f3pez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Critical Reviews in Oncology\/hematology. 2023; 181: 103841.","DOI":"10.1016\/j.critrevonc.2022.103841"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zhou J, Dai Y, Zuo Z, Liu T, Li S. Famine Exposure during Early Life and Risk of Cancer in Adulthood: A Systematic Review and Meta-Analysis. The Journal of Nutrition, Health & Aging. 2023; 27: 550\u2013558.","DOI":"10.1007\/s12603-023-1947-4"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Huang Z, Hu Z, Wong LP, Lin Y. Determinants of gastric cancer screening attendance in Southeastern China: a cross-sectional study. BMJ Open. 2023; 13: e073925.","DOI":"10.1136\/bmjopen-2023-073925"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Suzuki H, Oda I, Abe S, Sekiguchi M, Mori G, Nonaka S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016; 19: 198\u2013205.","DOI":"10.1007\/s10120-015-0469-0"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Long VD, Dat TQ, Thong DQ, Hai NV, Le Minh Quoc H, Nguyen DT, et al. Long-Term Outcomes of Open Versus Laparoscopic Distal Gastrectomy for T4a Gastric Cancer: A Propensity Score-Matched Cohort Study. Annals of Surgical Oncology. 2023; 30: 2278\u20132289.","DOI":"10.1245\/s10434-022-12897-z"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Castaneda M, den Hollander P, Kuburich NA, Rosen JM, Mani SA. Mechanisms of cancer metastasis. Seminars in Cancer Biology. 2022; 87: 17\u201331.","DOI":"10.1016\/j.semcancer.2022.10.006"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. Journal of Hematology & Oncology. 2022; 15: 129.","DOI":"10.1186\/s13045-022-01347-8"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Zhan J, Zhou L, Zhang H, Zhou J, He Y, Hu T, et al. A comprehensive analysis of the expression, immune infiltration, prognosis and partial experimental validation of CHST family genes in gastric cancer. Translational Oncology. 2024; 40: 101843.","DOI":"10.1016\/j.tranon.2023.101843"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wang D, Liu B, Zhang Z. Accelerating the understanding of cancer biology through the lens of genomics. Cell. 2023; 186: 1755\u20131771.","DOI":"10.1016\/j.cell.2023.02.015"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Huang S, Zhang Y, Shu H, Liu W, Zhou X, Zhou X. Advances of the MAPK pathway in the treatment of spinal cord injury. CNS Neuroscience & Therapeutics. 2024; 30: e14807.","DOI":"10.1111\/cns.14807"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Ye J, Wang J, Liu R, Chen C, Wang W. The prognostic significance and potential mechanism of PFDN4 in hepatocellular carcinoma. International Immunopharmacology. 2025; 145: 113761.","DOI":"10.1016\/j.intimp.2024.113761"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Yuan J, Dong X, Yap J, Hu J. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. Journal of Hematology & Oncology. 2020; 13: 113.","DOI":"10.1186\/s13045-020-00949-4"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Cho W, Jin X, Pang J, Wang Y, Mivechi NF, Moskophidis D. The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase\/Extracellular Signal-Regulated Kinase Signaling Pathways. Molecular and Cellular Biology. 2019; 39: e00391-18.","DOI":"10.1128\/MCB.00391-18"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Yuan W, Shi Y, Dai S, Deng M, Zhu K, Xu Y, et al. The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects. Journal of Translational Medicine. 2024; 22: 1142.","DOI":"10.1186\/s12967-024-05998-8"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Guo X, Peng Y, Song Q, Wei J, Wang X, Ru Y, et al. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients. Gastroenterology. 2023; 165: 402\u2013413.e13.","DOI":"10.1053\/j.gastro.2023.02.044"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. Journal of Hematology & Oncology. 2023; 16: 57.","DOI":"10.1186\/s13045-023-01451-3"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Molecular Cancer. 2022; 21: 104.","DOI":"10.1186\/s12943-022-01569-x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Paolillo M, Schinelli S. Extracellular Matrix Alterations in Metastatic Processes. International Journal of Molecular Sciences. 2019; 20: 4947.","DOI":"10.3390\/ijms20194947"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Peng L, Wen L, Shi QF, Gao F, Huang B, Meng J, et al. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death & Disease. 2020; 11: 978.","DOI":"10.1038\/s41419-020-03178-2"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhang M, Cao C, Li X, Gu Q, Xu Y, Zhu Z, et al. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer. Cancer Medicine. 2023; 12: 2075\u20132088.","DOI":"10.1002\/cam4.4975"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Vafaeie F, Nomiri S, Ranjbaran J, Safarpour H. ACAN, MDFI, and CHST1 as Candidate Genes in Gastric Cancer: A Comprehensive Insilco Analysis. Asian Pacific Journal of Cancer Prevention. 2022; 23: 683\u2013694.","DOI":"10.31557\/APJCP.2022.23.2.683"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Li R, Jiang WJ, Jin SL, Zhao RH, Cao XG, Zong H. Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer. Zhonghua Zhong Liu Za Zhi. 2020; 42: 115\u2013121.  (In Chinese)","DOI":"10.3760\/cma.j.issn.0253-3766.2020.02.006"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Yang Y, Chen Z, Zhou L, Wu G, Ma X, Zheng Y, et al. In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. Translational Cancer Research. 2022; 11: 1977\u20131993.","DOI":"10.21037\/tcr-22-168"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Gui L, Yu JH, Tan JN, Zhong GY, Wang YX, Zhong L, et al. CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration. Heliyon. 2025; 11: e42124.","DOI":"10.1016\/j.heliyon.2025.e42124"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Ma F, Yao J, Niu X, Zhang J, Shi D, Da M. MARK4 promotes the malignant phenotype of gastric cancer through the MAPK\/ERK signaling pathway. Pathology, Research and Practice. 2024; 261: 155471.","DOI":"10.1016\/j.prp.2024.155471"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Ma L, Hu X, Zhang W, Qi D, Chen L, Yin M. Weifuchun suppresses the malignancy of gastric cancer cells by targeting KPNA2 through miR-26a-5p-mediated destabilization and the deactivation of the MAPK signaling pathway. Journal of Ethnopharmacology. 2024; 334: 118538.","DOI":"10.1016\/j.jep.2024.118538"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Miao X, Liu Y, Fan Y, Wang G, Zhu H. LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1\/2 Pathway. Cancer Management and Research. 2021; 13: 287\u2013296.","DOI":"10.2147\/CMAR.S269679"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Wang H, Liang S, Du X, Zhao G, Bai Y, Li J, et al. RAB26 promotes prostate cancer progression via the MAPK\/ERK-TWIST1 signaling axis. Genes & Diseases. 2025; 12: 101689.","DOI":"10.1016\/j.gendis.2025.101689"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Hu Q, Chen X. MiR-27a-3p Enhances Endometrial Cancer Growth and EMT by Targeting LIFR and Activating the p38\/MAPK Pathways. Iranian Journal of Biotechnology. 2025; 23: e4008.","DOI":"10.30498\/ijb.2025.483853.4008"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Song YJ, Kim JE, Rajbongshi L, Lim YS, Ok YJ, Hwang SY, et al. Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells by Activating ERK\/MAPK Signaling Cascades. International Journal of Molecular Sciences. 2024; 26: 274.","DOI":"10.3390\/ijms26010274"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Sun B, Zhong FJ. ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK\/ERK Signaling by Regulating CSK. International Journal of General Medicine. 2021; 14: 4897\u20134911.","DOI":"10.2147\/IJGM.S325495"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/3\/10.31083\/FBL47627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:37:02Z","timestamp":1774949822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/3\/10.31083\/FBL47627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02018-6"],"URL":"https:\/\/doi.org\/10.31083\/fbl47627","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"47627"}}